CITIUS PHARMACEUTICALS INC (CTXR) Stock Balance Sheet
NASDAQ:CTXR - Nasdaq - US17322U2078 - Common Stock - Currency: USD
| MRQ (2024-12-31) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 1.10M | 3.25M | 26.48M | 41.70M | 70.10M | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Inventories | 14.38M | 8.27M | N/A | N/A | N/A | |||
| Other Current Assets | 2.85M | 2.70M | 7.89M | 2.90M | 2.70M | |||
| Total Current Assets | 18.33M | 14.22M | 34.37M | 44.60M | 72.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 191.41K | 246.25K | 455.86K | 700.00K | 800.00K | |||
| Goodwill | 9.35M | 9.35M | 9.35M | 9.30M | 9.30M | |||
| Intangibles | 92.80M | 92.80M | 59.40M | 59.40M | 59.40M | |||
| Other Non-Current Assets | 38.06K | 38.06K | 38.06K | 0.00 | 0.00 | |||
| Total Non-Current Assets | 102.38M | 102.43M | 69.24M | 69.40M | 69.60M | |||
| TOTAL ASSETS | 120.70M | 116.65M | 103.61M | 114.00M | 142.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 9.04M | 2.49M | 2.85M | 3.40M | 2.70M | |||
| Accounts Payable | 7.36M | 4.93M | 2.93M | 1.20M | 1.30M | |||
| Other Current Liabilities | 28.40M | 28.40M | N/A | N/A | N/A | |||
| Total Current Liabilities | 44.81M | 35.81M | 5.78M | 4.50M | 4.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 6.98M | 6.71M | 6.14M | 5.60M | 5.00M | |||
| Other Non-Current Liabilities | 0.00 | 21.32K | 262.87K | 500.00K | 700.00K | |||
| Total Non-Current Liabilities | 10.49M | 10.76M | 7.00M | 6.70M | 6.20M | |||
| TOTAL LIABILITIES | 55.30M | 46.57M | 12.78M | 11.20M | 10.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -211.14M | -201.37M | -162.23M | -129.70M | -96.00M | |||
| Additional Paid In Capital | 276.54M | 271.44M | 252.90M | 232.40M | 228.10M | |||
| Minority Interest | 3.51M | 4.02M | 600.38K | 600.00K | 600.00K | |||
| Common Shares | 7.73K | 7.25K | 158.86K | 100.00K | 100.00K | |||
| Shares Outstanding | 7.73M | 7.25M | 6.35M | 146.20M | 146.00M | |||
| Tangible Book Value per Share | -4.75 | -4.42 | 3.48 | 0.23 | 0.43 | |||
| Total Shareholders' Equity | 65.41M | 70.08M | 90.83M | 102.80M | 132.20M | |||
| TOTAL LIABILITIES AND EQUITY | 120.70M | 116.65M | 103.61M | 114.00M | 142.40M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 0.41 | 0.40 | 5.95 | 9.91 | 18.20 | |||
| Return On Assets (ROA) | -33.74% | -34.45% | -32.52% | -29.51% | -17.21% | |||
| Return On Equity (ROE) | -62.26% | -57.35% | -37.10% | -32.72% | -18.54% | |||
All data in USD , ROIC based on taxRate of 0.21